Sign in
Not yet taking people in United StatesNo phase

Virtual reality program for older adults with mild cognitive impairment

Tests a virtual reality program versus a tablet in older adults with mild cognitive impairment.

Key facts

Who runs it
Weill Medical College of Cornell University
Where
Champaign, New York, and Tallahassee, United StatesSee the 3 sites
Trial code
Registry title
Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 1
Status
Not yet recruiting
People taking part
108 people, planned
Started
31 Oct 2026
Expected to end
31 May 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Project 1 - Phase 2: VR Program for Social, Activity, and Cognitive Engagement
  • Project 1 - Phase 2: Tablet for Social, Activity, and Cognitive Engagement
Record updated
20 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for older adults to test a virtual reality program with brain, social and activity tasks. Healthy volunteers can join. The condition studied is mild cognitive impairment.

Age
65+ years of age in the inclusion criteria; the record lists a minimum age of 60 Years.
Sex
All sexes can join.

Main reasons for not taking part

  • Blindness or sight problems that make it hard to see the technology
  • Deafness or hearing problems that make it hard to answer phone questions
  • A life-limiting or terminal illness
  • Severe movement problems, such as severe tremors or hand arthritis, that affect speaking or use of the main hand
  • Long-term neck pain or injury that could make the headset uncomfortable

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • 65+ years of age
  • Able to read English at the 6th grade level
  • Have 20/60 vision with or without correction

Who cannot take part

  • Have a life-limiting/terminal illness
  • Severe motor impairment (e.g., severe tremors or debilitating arthritis in their hands) that impairs ability to speak or use dominant hand
  • Blind or have visual impairments that limit their ability to view the technology
  • Deaf or have hearing impairments that limit their ability to answer telephone queries
  • Chronic neck pain/injury that might make the headset uncomfortable

Where in United States

  • University of Illinois Urbana-ChampaignChampaign, United StatesContact: Wendy Rogers, PhDNot yet recruiting
  • Weill Cornell MedicineNew York, United StatesContact: Chelsie Burchett, MANot yet recruiting
  • Florida State UniversityTallahassee, United StatesContact: Chelsie Burchett, PhDNot yet recruiting

About the trial

What the trial wants to find out

Project 1: The goal of this research project is to examine usability and acceptance of virtual reality (VR) applications and their efficacy with older adults. This highly innovative cross-site Stage 1 Intervention Development Project (NIH (National Institutes of Health) Stage Model) will apply the CREATE systematic approach to the design and evaluation of an immersive VR program, Cognitive Activity Social Technology (CAST), for older adults. The program will provide a suite of virtual cognitive, social and activity engagement applications; and allow for virtual interactions.

The 2 groups in the trial

  • Project 1 - Phase 2: VR ProgramTreatment being tested

    Training will occur over 3 days and be conducted by research investigators in the participants' homes. Training will include training on the proper placement of the headset, the viewing lens, system headphones, and safety guidelines. The research investigator will aid in the set-up of the VR system in the home, which will be pre-loaded with applications, and will recommend an area to use the system to ensure a safe play area free of obstacles. Participants will be provided with practice tasks between training sessions. Participants will be provided with a "hands-on" performance assessment at the beginning of the second session and concepts/procedures that are problematic will be reviewed. Participants will be contacted one-week post training to determine if they are having any problems by study investigators. Following training, participants will use the CAST VR program and tablet at will, though encouraged to use it at least three times per week for 20 minutes.

    Treatment: Project 1 - Phase 2: VR Program for Social, Activity, and Cognitive Engagement

  • Project 1 - Phase 2: Active Control ConditionExisting treatment, for comparison

    Participants in the control condition will receive a tablet, internet support for 2 months and training (including training on cybersecurity). This will include instructions for accessing content similar to CAST VR, but in 2-D, so less immersive than that included in the VR program (e.g., virtual museum tours, One click, etc.). Participants will complete all assessments and will be provided with an Android tablet that has a 10.1" display, built in modem, and a front facing camera.

    Treatment: Project 1 - Phase 2: Tablet for Social, Activity, and Cognitive Engagement

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Center for Research and Education on Aging and Technology Enhancement - CREATE V
Plain-language title
Virtual reality program for older adults with mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
20 August 2026
Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 1 (NCT05811338) – Frontlight Research